Interim data refers to the preliminary results collected during an ongoing clinical trial before the study has been fully completed. These data sets provide an early look at the efficacy and safety of a treatment, which can be crucial for decision-making in cancer research. Given the urgency often associated with cancer therapies, interim data can offer significant insights that may influence the course of a clinical trial.
